These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36648839)

  • 1. Assessment of the Antimalarial Treatment Failure in Ebonyi State, Southeast Nigeria.
    Egwu CO; Aloke C; Chukwu J; Nwankwo JC; Irem C; Nwagu KE; Nwite F; Agwu AO; Alum E; Offor CE; Obasi NA
    J Xenobiot; 2023 Jan; 13(1):16-26. PubMed ID: 36648839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of artemisinin-based antimalarial drugs marketed in Nigeria.
    Izevbekhai O; Adeagbo B; Olagunju A; Bolaji O
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):90-96. PubMed ID: 28460126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study.
    Bassi PU; Osakwe AI; Isah A; Suku C; Kalat M; Jalo I; Wammanda RD; Ugochukwu C; Adesina O; Nyong EE; Osungwu F; Pal S; Nwoasu SC; Wallberg M; Coulter D
    Drug Saf; 2013 Sep; 36(9):747-56. PubMed ID: 23591829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs use pattern for uncomplicated malaria in medicine retail outlets in Enugu urban, southeast Nigeria: implications for malaria treatment policy.
    Ezenduka CC; Ogbonna BO; Ekwunife OI; Okonta MJ; Esimone CO
    Malar J; 2014 Jun; 13():243. PubMed ID: 24961280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cross-Sectional Evaluation of the Use of Artemisinin-Based Combination Therapy for Treatment of Malaria Infection at a Tertiary Hospital in Nigeria.
    Okoro RN; Jamiu MO
    J Trop Med; 2018; 2018():2025858. PubMed ID: 29887894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
    Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
    de Haan F; Bolarinwa OA; Guissou R; Tou F; Tindana P; Boon WPC; Moors EHM; Cheah PY; Dhorda M; Dondorp AM; Ouedraogo JB; Mokuolu OA; Amaratunga C
    PLoS One; 2021; 16(8):e0256567. PubMed ID: 34464398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mind the gap: knowledge and practice of providers treating uncomplicated malaria at public and mission health facilities, pharmacies and drug stores in Cameroon and Nigeria.
    Mangham-Jefferies L; Hanson K; Mbacham W; Onwujekwe O; Wiseman V
    Health Policy Plan; 2015 Nov; 30(9):1129-41. PubMed ID: 25339637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Artemisinin-based Combination Therapy for malaria found in Ghanaian markets and public health implications of their use.
    Tivura M; Asante I; van Wyk A; Gyaase S; Malik N; Mahama E; Hostetler DM; Fernandez FM; Asante KP; Kaur H; Owusu-Agyei S
    BMC Pharmacol Toxicol; 2016 Oct; 17(1):48. PubMed ID: 27788677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders' perspectives in Burkina Faso and Nigeria.
    Tindana P; Guissou R; Bolarinwa OA; Tou F; de Haan F; Dhorda M; Dondorp AM; Amaratunga C; Mokuolu OA; Ouedraogo JB; Cheah PY
    PLoS One; 2022; 17(9):e0273249. PubMed ID: 36083995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique.
    Silva-Pinto A; Domingos J; Cardoso M; Reis A; Benavente ED; Caldas JP; Conceição C; Toscano C; Baptista-Fernandes T; Clark TG; Mansinho K; Campino S; Nogueira F
    Int J Infect Dis; 2021 Sep; 110():151-154. PubMed ID: 34242769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple field assays to check quality of current artemisinin-based antimalarial combination formulations.
    Ioset JR; Kaur H
    PLoS One; 2009 Sep; 4(9):e7270. PubMed ID: 19789707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of introducing subsidized combination treatment with artemether-lumefantrine on sales of anti-malarial monotherapies: a survey of private sector pharmacies in Huambo, Angola.
    Lussiana C; Floridia M; Martinho do Rosário J; Fortes F; Allan R
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):588-596. PubMed ID: 27856948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic failure after regimen with artemether-lumefantrine combination therapy: a report of three cases in Benin City, Nigeria.
    Ebohon O; Irabor F; Ebohon LO; Omoregie ES
    Rev Soc Bras Med Trop; 2019; 52():e20190163. PubMed ID: 31618306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health workers' perception of malaria rapid diagnostic test and factors influencing compliance with test results in Ebonyi state, Nigeria.
    Obi IF; Sabitu K; Olorukooba A; Adebowale AS; Usman R; Nwokoro U; Ajumobi O; Idris S; Nwankwo L; Ajayi IO
    PLoS One; 2019; 14(10):e0223869. PubMed ID: 31622398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study.
    Zoleko-Manego R; Okwu DG; Handrich C; Dimessa-Mbadinga LB; Akinosho MA; Ndzebe-Ndoumba WF; Davi SD; Stelzl D; Veletzky L; Kreidenweiss A; Nordmann T; Adegnika AA; Lell B; Kremsner PG; Ramharter M; Mombo-Ngoma G
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010899. PubMed ID: 36315579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Declining responsiveness of childhood Plasmodium falciparum infections to artemisinin-based combination treatments ten years following deployment as first-line antimalarials in Nigeria.
    Sowunmi A; Ntadom G; Akano K; Ibironke FO; Ayede AI; Agomo C; Folarin OA; Gbotosho GO; Happi C; Oguche S; Okafor HU; Meremikwu M; Agomo P; Ogala W; Watila I; Mokuolu O; Finomo F; Ebenebe JC; Jiya N; Ambe J; Wammanda R; Emechebe G; Oyibo W; Useh F; Aderoyeje T; Dokunmu TM; Alebiosu OT; Amoo S; Basorun OK; Wewe OA; Okafor C; Akpoborie O; Fatunmbi B; Adewoye EO; Ezeigwe NM; Oduola A
    Infect Dis Poverty; 2019 Aug; 8(1):69. PubMed ID: 31383040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.